Palantir Has a Hand in NIH’s Most Ambitious Health Initiative
By Julia Métraux,
Mother Jones [cites CGS' Katie Hasson]
| 07. 07. 2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes, and to give all of us access to the personalized information we need to keep ourselves and our families healthier,” Obama said with confidence. “We can do this.” He was met with applause.
That announcement introduced the National Institutes of Health’s “All of US” initiative, designed to organize and provide to researchers the health data of up to a million Americans who opted in to donate their blood, general electronic health records, and more. People’s names are replaced with a code before researchers access their data, and NIH asserts that only a few people have access to the list of codes that correspond with names. As of late June, data from nearly 750,000 participants is available to researchers who are studying such diseases like Alzheimer’s disease and diabetes, as well as overall health patterns like sleep.
Since then...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Editorial Staff, The Guardian | 07.05.2026
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become increasingly urgent. There is already a worldwide legal prohibition. No country currently allows human germline editing (meaning genetic changes...